GlaxoSmithKline Biologicals
Rixensart, Antwerpen, Belgium
Purpose
to manufacture clinical lots of HIV proteins for efficacy evaluation of poxvirus/protein prime-boost regimes in Southern Africa
Division
Global Health
Date
November 2011
Region Served
GLOBAL
Committed amount
$16,949,656
Grant topic
HIV
Duration (months)
96
Grantee location
Rixensart, Antwerpen, Belgium
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.